# Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention

> **NCT03996057** · PHASE4 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- UTI
- Female Urogenital Diseases
- UTI - Lower Urinary Tract Infection

## Interventions

- **DRUG:** Methenamine Hippurate 1000 MG
- **DRUG:** Vaginal estrogen
- **DIETARY_SUPPLEMENT:** D-mannose

## Key facts

- **NCT ID:** NCT03996057
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-20
- **Primary completion:** 2022-02-11
- **Final completion:** 2022-02-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Project canceled due to PI leaving institution, staff changes and COVID

Project canceled for other reason , describe: - Due to staff changes and COVID

Project canceled due to PI leaving, staff changes and COVID
- **Last updated:** 2022-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03996057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03996057, "Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03996057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*